A Study on Preparation of 3'-Fluoro-3'-deoxythymidine and Its Biodistribution in 9L Glioma Bearing Rats |
Shim, Ah-Young
(Laboratory of Radiopharmaceuticals, Korea Institute of Radiological and Medical Sciences)
Moon, Byung-Seok (Laboratory of Radiopharmaceuticals, Korea Institute of Radiological and Medical Sciences) Lee, Tae-Sup (Laboratory of Nuclear Medicine, Korea Institute of Radiological and Medical Sciences) Lee, Kyo-Chul (Laboratory of Radiopharmaceuticals, Korea Institute of Radiological and Medical Sciences) An, Gwang-Il (Laboratory of Radiopharmaceuticals, Korea Institute of Radiological and Medical Sciences) Yang, Seung-Dae (Laboratory of Radiopharmaceuticals, Korea Institute of Radiological and Medical Sciences) Yu, Kook-Hyun (Department of Chemistry,Dongguk University) Cheon, Gi-Jeong (Laboratory of Radiopharmaceuticals, Korea Institute of Radiological and Medical Sciences) Choi, Chang-Woon (Laboratory of Nuclear Medicine, Korea Institute of Radiological and Medical Sciences) Lim, Sang-Moo (Laboratory of Nuclear Medicine, Korea Institute of Radiological and Medical Sciences) Chun, Kwon-Soo (Laboratory of Radiopharmaceuticals, Korea Institute of Radiological and Medical Sciences) |
1 | Eriksson S, Kierdaszuk B, Munch-Peterson B, Oberg B, Johnsson NG. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biophys Res Commun 1991;176: 586-92 DOI ScienceOn |
2 | Kong XB, Zhu QY, Vidal PM, Watanabe KA, Polsky B, Armstrong D, et al.. Comparison of anti-human immunodeficiency virus activities, cellular ransport, and plasma and intracellular pharmacokinatics of 3-fluoro-3-deoxythymidine and 3-azido-3- deoxytbymidine. Antimicrob Agent Chemother Biochem 1992; 36:808-18 DOI ScienceOn |
3 | Tjuvajev J, Muraki A, Ginos J, Berk J, Koutcher D, Ballon B. Iododeoxyuridine (IUDR) uptake and retention as a measure of tumor growth. J Nucl Med 1993;34:1152-61 |
4 | Grierson JR, Shields AF. Radiosynthesis of 3-deoxy-3 -[]fluorothymidine: []FLT for imaging of cellular proliferation in vivo. Nucl Med Biol 2000;27:143-56 DOI ScienceOn |
5 | Martin SJ, Eisenbarth JA, Wagner-Utermann U, Mier W, Henze M, Pritzkow H, et al. A new precursor for the radiosynthesis of []FLT. Nucl Med Biol 2002;29:263-73 DOI ScienceOn |
6 | Wodarski C, Eisenbarth J, Weber K, Henze M, Haberkorn U, Eisenhut M. Synthesis of 3'-deoxy-3'-[fluorothymidine with 2,3'-anthydro-5'-O-(4,4'-dimethoxytrityl) thymidine. J Labelled Cpd Radiopharm 2000:43:1211-8 DOI ScienceOn |
7 | Schwartz JL, Tamura Y, Jordan R, Grierson JR, Krohn KA. Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs. J Nucl Med 2003;44:2027-32 |
8 | Moon BS, Kim SW, Lee TS, Ahn SH, Lee KC, An GI, et al. Synthesis of O-(3-[]fluoropropyl)-L-tyrosine (L-[]FPT) and its biological evaluation in 9L tumor bearing rat. Bull Korean Chem Soc 2005;26:91-6 DOI |
9 | Lu L, Samuelsson L, Bergstrom M, Sato K, Fasth KJ, Langstrom B. Rat studies comparing -FMAU, -FLT, and -BFU as proliferation markers. J Nucl Med 2002;43:1688-98 |
10 | Rasey JS, Grierson JR, Wiens LW, Kolb PD, Schwartz JL. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med 2002;43:1210-7 |
11 | Mangner TJ, Klecker RW, Anderson L, Shields AF. Synthesis of 2'-deoxy -2'-[]fluoro-beta-D-arabinofuranosyl nucleosides, []FAU, []FMAU, []FBAU and []FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of []labelled FAU, FMAU, FBAU, FlAU. Nucl Med Biol 2003;30:215-24 DOI ScienceOn |
12 | Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L, et al. Imaging proliferation in brain tumors with -FLT PET: comparison with -FDG. J Nucl Med 2005;46:945-52 |
13 | Choi SJ, Kim JS, Kim JH, Oh SJ, Lee JG, Kim CJ, et al. 3′-deoxy-3-[]fluorothymidine PET for the diagnosis and grading of brain tumors. Eur J Nucl Med Mol Imaging 2005;32:653-9 DOI ScienceOn |
14 | Higashi K, Clavo AC, Wahl RL. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 1993;34:414-9 |
15 | Shields AF, Grierson JR, Dohmen BR, Machulla H-J, Stayanoff JC, Lawhorn-Crews JM, et al. Imaging proliferation in vivo with []FLT and positron emission tomography. Nat Med 1998;4:1334-6 DOI ScienceOn |
16 | Toyoharaa J, Wakib A, Takamatsub S, Yonekurab Y, Magatac Y, Fujibayashib Y. Basis of FLT as a cell proliferation marker: comparative uptake studies with []thymidine and []arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines. Nucl Med Biol 2001;29:281-7 |
17 | Eary JF, Mankoff DA, Spence AM, Berger MS, Olshen A, Link JM, et al. 2-[]thymidine imaging of malignant brain tumors. Cancer Res 1999;59:615-21 |
18 | Martiat P, Ferrant A, Labar D, Cogneau A, Boc C, Michel JL, et al. In vivo measurement of carbon-11 thymidine uptake in non-Hodgikin's lymphoma using positron emission tomography. J Nucl Med 1998;29:1633-7 |
19 | Shields AF, Mankoff DA, Link JM, Graham MM, Eary JF, Kozawa SM, et al. Carbon-11-thymidine and FDG to measure therapy response. J Nucl Med 1998;39:1757-62 |
20 | Tjuvajev JG, Macapinlac HA, Daghighian F, Scott AM, Ginos JZ, Finn RD, et al. Imaging of the brain tumor proliferative activity with []iododeoxyuridine. J Nucl Med 1994;35:1407-17 |